Retrospective analysis of false positive ratio of our patients with lung cancer at positron emission tomography-CT screen

Basit Öğe Kaydı
dc.contributor.authorKapicibasi, Hasan Oguz
dc.contributor.authorMutlu, Pinar
dc.contributor.authorAlkan, Sahinur Aycan
dc.contributor.authorMirici, Nihal Arzu
dc.contributor.authorYuksel, Buse
dc.contributor.authorBakar, Coskun
dc.date.accessioned2025-01-27T21:19:56Z
dc.date.available2025-01-27T21:19:56Z
dc.date.issued2020
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractBACKGROUND: In lung cancer, staging is necessary to give the best treatment to the patient and to estimate the best prognosis. The aim of this study was to compare the pathology results of the lung masses and mediastinal lymph nodes and to evaluate the sensitivity and specificity values of positron emission tomography-computerized tomography (PET-CT) and to determine the maximal threshold of maximum standardized uptake volume (SUVmax). MATERIALS AND METHODS: We retrospectively evaluated the PET-CT SUVmax values and pathology results of the patients who had a mass, mediastinal lymph node, or scalene lymph node in our patients between 2016 and 2018. RESULTS: Fifty-one people and 75 pathology materials were included in our study. We used the receiver operating characteristic curve analysis to determine the cutoff value for SUVmax value and calculated the cutoff value as 6.65. In our study, the sensitivity and specificity were calculated as 63% and 71%, respectively. We calculated the positive predictive value as 73.5% and the negative predictive value as 61%. CONCLUSION: As a result, considering the common inflammatory and granulomatous diseases seen in our country, we concluded that benign diseases should be considered before malignancy in SUVmax value below 6.6. We continue to add new patients and new data to our study to find the most appropriate threshold of SUVmax value for the health values of our country.
dc.identifier.doi10.4103/ejop.ejop_75_18
dc.identifier.endpage28
dc.identifier.issn2148-3620
dc.identifier.issn2148-5402
dc.identifier.issue1
dc.identifier.startpage23
dc.identifier.trdizinid367623
dc.identifier.urihttps://doi.org/10.4103/ejop.ejop_75_18
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/367623
dc.identifier.urihttps://hdl.handle.net/20.500.12428/28778
dc.identifier.volume22
dc.identifier.wosWOS:000615072300003
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.publisherWolters Kluwer Medknow Publications
dc.relation.ispartofEurasian Journal of Pulmonology
dc.relation.publicationcategoryinfo:eu-repo/semantics/openAccess
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20250125
dc.subjectDiagnosis
dc.subjectfalse positive
dc.subjectlung cancer
dc.subjectpositron emission tomography-computerized tomography
dc.subjecttuberculosis
dc.titleRetrospective analysis of false positive ratio of our patients with lung cancer at positron emission tomography-CT screen
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu